Emily Reeve Selected Research

Deprescriptions

1/2022	Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial.
1/2022	Development, validation and evaluation of the Goal-directed Medication review Electronic Decision Support System (G-MEDSS)©.
12/2020	Designing a Primary Care-Based Deprescribing Intervention for Patients with Dementia and Multiple Chronic Conditions: a Qualitative Study.
1/2019	Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary.
12/2018	Development and pilot testing of the revised Patients' Attitudes Towards Deprescribing questionnaire for people with cognitive impairment.
3/2017	Deprescribing: A narrative review of the evidence and practical recommendations for recognizing opportunities and taking action.
10/2015	Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia.
1/2015	Barriers to Optimising Prescribing and Deprescribing in Older Adults with Dementia: A Narrative Review.
10/2014	The benefits and harms of deprescribing.
2/2014	Benefits of deprescribing on patients' adherence to medications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emily Reeve Research Topics

Disease

10	Drug-Related Side Effects and Adverse Reactions 12/2020 - 02/2014
9	Dementia (Dementias) 01/2022 - 06/2014
5	Frailty 01/2021 - 10/2015
4	Cognitive Dysfunction 01/2022 - 12/2018
3	Chronic Disease (Chronic Diseases) 01/2021 - 01/2020
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 10/2015
1	COVID-19 01/2021
1	Sarcopenia 01/2021
1	Multiple Chronic Conditions 12/2020
1	Myocardial Infarction 10/2020
1	Heart Failure 10/2020
1	Hypertension (High Blood Pressure) 10/2020
1	Chronic Renal Insufficiency 10/2020
1	Stroke (Strokes) 10/2020
1	Wounds and Injuries (Trauma) 01/2019
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 08/2017
1	Sleep Initiation and Maintenance Disorders (Insomnia) 08/2017
1	Orthostatic Hypotension (Postural Hypotension) 01/2017
1	Pain (Aches) 06/2014

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 10/2020 - 01/2017
2	5-methoxy-methylindoleacetic acid (DBI)IBA 01/2019 - 01/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2015 - 10/2015
1	Antihypertensive Agents (Antihypertensives)IBA 10/2020
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2019
1	Memantine (Namenda)FDA Link 01/2019
1	BenzodiazepinesIBA 08/2017
1	ORALIT (ORS)IBA 06/2014
1	Analgesics (Analgesic Drugs)IBA 06/2014

Therapy/Procedure

14	Polypharmacy 01/2021 - 02/2014
10	Deprescriptions 01/2022 - 02/2014
2	Activities of Daily Living (ADL) 01/2021 - 06/2014
1	Enteral Nutrition (Feeding, Tube) 01/2021
1	Drug Therapy (Chemotherapy) 01/2019
1	Inappropriate Prescribing 05/2015